Related Experiment Video

Updated: Apr 17, 2026

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells
11:38

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

Published on: November 26, 2018

11.2K

Molecular mechanisms of induced pluripotency

Katarzyna Kulcenty1, Joanna Wróblewska1, Sylwia Mazurek2

  • 1Department of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland ; Gene Therapy Laboratory, Department of Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland.

Contemporary Oncology (Poznan, Poland)
|February 19, 2015
PubMed

Insights

Induced pluripotent stem cells (iPSCs) are generated by reprogramming differentiated cells using Yamanaka factors (OKSM). This review covers the molecular mechanisms, phases of reprogramming, and various strategies for inducing pluripotency.

Area of Science:

  • Stem cell biology
  • Molecular biology
  • Genetics

Background:

  • Cellular pluripotency and differentiation are key areas in developmental biology.
  • Induced pluripotent stem cells (iPSCs) offer a route to reverse cell fate.
  • The Yamanaka factors (Oct3/4, Sox2, Klf4, c-Myc) are crucial for reprogramming.

Purpose of the Study:

  • To review the molecular events driving pluripotency induction by Yamanaka factors.
  • To discuss different reprogramming strategies and their associated pros and cons.
  • To explore laboratory approaches for inducing pluripotency in various cell types.

Main Methods:

  • Genetic manipulation to overexpress specific transcription factors.
  • Analysis of molecular events during the reprogramming process.
  • Comparative review of different pluripotency induction strategies.

Main Results:

  • Forced expression of Oct3/4, Sox2, Klf4, and c-Myc (OKSM) can reprogram somatic cells into iPSCs.
  • Reprogramming involves distinct stochastic and hierarchical phases.
  • Various reprogramming strategies exist, each with specific advantages and disadvantages.

Conclusions:

  • Understanding the molecular mechanisms of pluripotency induction is critical for regenerative medicine.
  • The OKSM factors initiate a complex cascade of genetic changes.
  • Further research into optimizing reprogramming techniques is essential for diverse cell types.
Keywords:
OKSMcellular reprogramminginduced pluripotent stem cells

More Related Videos

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells08:01

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells

Published on: August 29, 2020

2.8K
A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening07:18

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

6.9K

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.4K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

4.1K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K